These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8781575)

  • 1. DNA adducts from chemotherapeutic agents.
    Lawley PD; Phillips DH
    Mutat Res; 1996 Aug; 355(1-2):13-40. PubMed ID: 8781575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of alkylating agents towards sensitive and resistant strains of Escherichia coli in relation to extent and mode of alkylation of cellular macromolecules and repair of alkylation lesions in deoxyribonucleic acids.
    Lawley PD; Brookes P
    Biochem J; 1968 Sep; 109(3):433-47. PubMed ID: 4879534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monofunctional derivative of melphalan: preparation, DNA alkylation products, and determination of the specificity of monoclonal antibodies that recognize melphalan-DNA adducts.
    Tilby MJ; McCartney H; Gould KA; O'Hare CC; Hartley JA; Hall AG; Golding BT; Lawley PD
    Chem Res Toxicol; 1998 Oct; 11(10):1162-8. PubMed ID: 9778312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance.
    Spiro T; Liu L; Gerson S
    Forum (Genova); 2000; 10(3):274-85. PubMed ID: 11007934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of base excision repair in the repair of DNA adducts formed by a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size.
    Brooks N; McHugh PJ; Lee M; Hartley JA
    Anticancer Drug Des; 1999 Feb; 14(1):11-8. PubMed ID: 10363024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative toxicities of DNA cross-links and monoadducts: new insights from studies of decarbamoyl mitomycin C and mitomycin C.
    Palom Y; Suresh Kumar G; Tang LQ; Paz MM; Musser SM; Rockwell S; Tomasz M
    Chem Res Toxicol; 2002 Nov; 15(11):1398-406. PubMed ID: 12437330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of melphalan-DNA adducts in colon cancer cells in vitro and human colorectal liver tumours in vivo.
    Rothbarth J; Koevoets C; Tollenaar RA; Tilby MJ; van de Velde CJ; Mulder GJ; Kuppen PJ
    Biochem Pharmacol; 2004 May; 67(9):1771-8. PubMed ID: 15081876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Cross-Link for an Old Cross-Linking Drug: The Nitrogen Mustard Anticancer Agent Mechlorethamine Generates Cross-Links Derived from Abasic Sites in Addition to the Expected Drug-Bridged Cross-Links.
    Nejad MI; Johnson KM; Price NE; Gates KS
    Biochemistry; 2016 Dec; 55(50):7033-7041. PubMed ID: 27992994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a PCR-based assay for the selection of patients more likely to benefit from therapeutic treatment with alkylating drugs.
    Stefanou DT; Episkopou H; Kyrtopoulos SA; Bamias A; Gkotzamanidou M; Bamia C; Liakou C; Bekyrou M; Sfikakis PP; Dimopoulos MA; Souliotis VL
    Br J Clin Pharmacol; 2012 Nov; 74(5):842-53. PubMed ID: 22432918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreparable DNA cross-links and mammalian cell lethality with bifunctional alkylating agents.
    Murnane JP; Byfield JE
    Chem Biol Interact; 1981 Dec; 38(1):75-86. PubMed ID: 7326808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
    Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells.
    Chijiwa S; Masutani C; Hanaoka F; Iwai S; Kuraoka I
    Carcinogenesis; 2010 Mar; 31(3):388-93. PubMed ID: 20015866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-specific formation and repair of DNA monoadducts and interstrand cross-links after therapeutic exposure to nitrogen mustards.
    Souliotis VL; Dimopoulos MA; Sfikakis PP
    Clin Cancer Res; 2003 Oct; 9(12):4465-74. PubMed ID: 14555520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents.
    Damia G; Imperatori L; Stefanini M; D'Incalci M
    Int J Cancer; 1996 Jun; 66(6):779-83. PubMed ID: 8647649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkylation damage in DNA and RNA--repair mechanisms and medical significance.
    Drabløs F; Feyzi E; Aas PA; Vaagbø CB; Kavli B; Bratlie MS; Peña-Diaz J; Otterlei M; Slupphaug G; Krokan HE
    DNA Repair (Amst); 2004 Nov; 3(11):1389-407. PubMed ID: 15380096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of DNA adducts, hypermutation and acquisition of cellular resistance to alkylating agents in glioblastoma.
    Head RJ; Fay MF; Cosgrove L; Y C Fung K; Rundle-Thiele D; Martin JH
    Cancer Biol Ther; 2017 Dec; 18(12):917-926. PubMed ID: 29020502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 elevation in relation to levels and cytotoxicity of mono- and bifunctional melphalan-DNA adducts.
    Gould KA; Nixon C; Tilby MJ
    Mol Pharmacol; 2004 Nov; 66(5):1301-9. PubMed ID: 15308759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of DNA Alkylation Damage Repair: Lessons and Therapeutic Opportunities.
    Soll JM; Sobol RW; Mosammaparast N
    Trends Biochem Sci; 2017 Mar; 42(3):206-218. PubMed ID: 27816326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation and identification of trinucleotide-melphalan adducts from enzymatically digested DNA using HPLC-ESI-MS.
    Mohamed D; Linscheid M
    Anal Bioanal Chem; 2008 Nov; 392(5):805-17. PubMed ID: 18622599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody recognition of melphalan adducts characterized using immobilized DNA: enhanced alkylation of G-Rich regions in cells compared to in vitro.
    McCartney H; Martin AM; Middleton PG; Tilby MJ
    Chem Res Toxicol; 2001 Jan; 14(1):71-81. PubMed ID: 11170510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.